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Norovirus infections are a major cause of acute viral gastro-
enteritis and a significant burden on global human health. A
vital process for norovirus replication is the processing of the
nonstructural polyprotein by a viral protease into the viral com-
ponents required to form the viral replication complex. This
cleavage occurs at different rates, resulting in the accumulation
of stable precursor forms. Here, we characterized how precursor
forms of the norovirus protease accumulate during infection.
Using stable forms of the protease precursors, we demonstrated
that all of them are proteolytically active in vitro, but that when
expressed in cells, their activities are determined by both substrate
and protease localization. Although all precursors could cleave a
replication complex-associated substrate, only a subset of precur-
sors lacking the NS4 protein were capable of efficiently cleaving a
cytoplasmic substrate. By mapping the full range of protein–
protein interactions amongmurine andhumannorovirus proteins
with the LUMIER assay, we uncovered conserved interactions
betweenreplicationcomplexmembers thatmodify the localization
of a protease precursor subset. Finally, we demonstrate that fusion
to themembrane-bound replicationcomplex componentspermits
efficient cleavage of a fused substrate when active polyprotein-de-
rivedprotease is provided in trans. These findingsoffer amodel for
how norovirus can regulate the timing of substrate cleavage
throughout the replication cycle. Because the norovirus protease
represents a key target in antiviral therapies, an improved under-
standing of its function and regulation, as well as identification of
interactions among the other nonstructural proteins, offers new
avenues for antiviral drug design.
Noroviruses are the causative agent of winter vomiting dis-
ease, and following the introduction of the rotavirus vaccine,
a leading cause of viral gastroenteritis worldwide. Although
models for human norovirus infection have recently been
developed (1, 2), due to the availability of efficient cell culture
and robust reverse genetics systems,murine norovirus (MNV)4
has been widely used to dissect the molecular details of viral
translation and replication (3–5).
Noroviruses are small, nonenveloped positive sense RNA
viruses (ssRNA) forming a genus within the Caliciviridae
family. As observed with many otherssRNA viruses, norovi-
ruses generate themajority of the viral replicase components by
cleavage of a long polyprotein by the viral protease NS6 (Fig.
1A) (6). A key benefit of this strategy is that due to differing rates
of cleavage, polyproteinprocessing generates both the fully pro-
cessed products and a range of stable precursor intermediates
(6, 7). The role of polyprotein precursors in viral replication
have been studied extensively for the Picornaviridae, which
share similarities in their polyprotein organization (8). For
noroviruses, however, the sole precursor to be examined to date
in any detail is the NS6–NS7 precursor (also known as Pro-Pol
or 3CD) (9, 10). Cleavage of the NS6–7 junction is known to
be essential for norovirus viability and the NS6–NS7 precur-
sor retains both protease and polymerase activities (9, 10). In
contrast, for some members of the Caliciviridae, whereas a
cleavage site between NS6 and NS7 is present, this precursor
remains uncleaved (11).
Precursor protein functions are often distinct from those of
the fully cleaved mature products (12). The rate of precursor
cleavage and accumulation can also regulate key stages of the
viral replication cycle; for example, the cleavage of alphavirus
nonstructural proteins from the P123 and P1234 polyproteins
provides temporal regulation of sense and antisense RNA tran-
script synthesis (13). In addition to cleaving viral substrates,
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viral proteases also target cellular proteins. We recently identi-
fied the host protein poly(A)-binding protein (PABP) as a target
of the norovirus protease, particularly at late stages in the viral
life cycle. The cleavage of PABP forms part of a viral strategy to
inhibit host translation, and therefore the production of inter-
feron-stimulated genes (14). However, the means by which
PABP cleavage was restricted to late times post-infection was
unclear.
Processing of the norovirus polyprotein by NS6 results in the
production of six proteins; NS1/2, NS3, NS4, NS5, NS6, and
NS7 (15) (Fig. 1). NS5 functions as both a protein primer for
RNA synthesis, as well as permitting translation of the viral
genome through interactions with the host translation initia-
tion complex (16, 17). NS6 (also known as Pro, 3C-like) and
NS7 (3DPol, RdRP) encode the 3C-like protease and RNA-de-
pendent RNA polymerase, respectively. The N-terminal 3 pro-
teins are less well characterized but are known to localize to
cytoplasmic membranes. NS1/2 localizes to the endoplasmic
reticulum (18), and is implicated in viral persistence (19). NS3
hasNTPase (20) and predicted RNAhelicase activities, andwas
recently shown to interact with cholesterol-rich membranes
and cytoskeletal proteins (21). NS4, an orthologue of the picor-
navirus 3A protein, is localized to endosomes (18).
In this study we identify a mechanism by which noroviruses
regulate viral protease cleavage of substrates during the viral
replication cycle. We demonstrate how polyprotein processing
controls protease localization and as a result, substrate accessi-
bility, providing amechanism for temporal regulation of prote-
ase cleavage of substrates. Furthermore, we have demonstrated
that a comprehensive network of protein–protein interactions
occur between the viral replicase proteins, which also regulates
protease and precursor localization. Finally we demonstrate
that targeting an artificial substrate to the viral replication com-
plex allows cleavage by polyprotein-derived protease provided
in trans. As the polyprotein includes key drug targets including
the protease and polymerase (22, 23), an improved understand-
ing of how these proteins function and are regulated through-
out the viral life cycle may aid drug design and targeting.
Results
The norovirus protease cleaves a cytoplasmic FRET substrate
upon transfection but not in the context of infection
We sought to examine whether norovirus protease precur-
sors play an important role in regulating substrate cleavage. To
this aim, we compared the ability of the NS6 protease to cleave
an artificial substrate when produced either as a fully processed
form or produced during authentic viral replication. We have
previously reported the generation of a FRET sensor for assess-
ing norovirus protease activity in live cells (7). This FRET sen-
sor consists of CFP fused to YFP via a short linker region con-
sisting of the P7 to P7 region of the MNV NS1/2–3 cleavage
site (Fig. 1B). Although the expression of the mature protease
resulted in efficient cleavage of the sensor, recapitulating our
previous results, protease produced during viral infection
showed extremely poor cleavage of the FRET sensor (Fig. 1C).
Western blotting for NS6 protein confirmed the presence of
higher molecular weight isoforms of NS6 during infection
(Fig. 1C). These higher molecular weight proteins likely repre-
sent precursor forms of the protease, that we and others have
observed previously (6, 7).
To examine whether poor cleavage of the FRET substrate
during infection was due to a mismatch between substrate and
protease localization, the localization of the protease and sen-
sor was examined following transfection or infection of HeLa
cells expressing the recently identified MNV receptor CD300lf
(24, 25). Confocal microscopy revealed that the FRET sensor
displayed diffuse nuclear and cytoplasmic localization, in both
transfected and infected cells (Fig. 1D). Although NS6 pro-
duced following transfection showed the same diffuse localiza-
tion as the FRET sensor, in infected cells NS6 was located pri-
marily to large perinuclear puncta, consistent with previous
observations (17) and most likely reflecting the position of the
viral replication complex (RC). Given that theNS6 antisera rec-
ognizes both mature and precursor forms of NS6, the localiza-
tion pattern likely represents an averaged localization for both
mature NS6 and NS6-containing precursors. These data sug-
gest that substrate cleavage during infection is likely impacted
by precursor and substrate localization, and that the context in
which NS6 is expressed may affect the relative efficiency with
which a substrate is cleaved.
Targeting a cytoplasmic substrate to the replication complex
permits efficient cleavage by NS6
To determine whether poor substrate-protease co-localiza-
tion was responsible for the low levels of cleavage observed
during infection we fused the FRET substrate to the C terminus
of NS7 in the context of full-length polyprotein, with either a
WT (ORF1-FRET-WT) or a catalytically inactive protease
domain (ORF1-FRET-H30A), to drive RC localization. Poly-
protein processing was unaffected by fusion to the FRET sensor
as the relative level of mature NS5 and NS5-containing precur-
sors was similar to those generated from a MNV full-length
infectious clone (MNV-FLC-WT, Fig. 2A). The FRET sensor
was efficiently cleaved in the context of the ORF1-FRET-WT
construct, producing a70 kDa NS7-CFP fusion product that
was increased in mass when expressed in the context of ORF1
with a catalytically inactive protease (ORF1-FRET-H30A) (Fig.
2A). We also observed that the fusion of the FRET sensor to
ORF1 resulted in RC localization as the CFP signal localized to
the perinuclear region where the RC is known to form (Fig. 2B).
As expected, the RC localization of the YFP component of the
FRET sensorwasmore pronouncedwhen expressed in the con-
text of ORF1 with a catalytically inactive protease (ORF1-
FRET-H30A, Fig. 2B). These data confirm that targeting of an
artificial protease substrate to the RC allows for efficient cleav-
age of the substrate, adding to our hypothesis that protease
localization and/or the context in which the protease is
expressed, affects substrate cleavage efficiency.
NS6-containing precursors are abundant and expressed from
early times in infection
The processing of the norovirus polyprotein by NS6 at the
five known cleavage sites would, in principle, result in the gen-
eration of 21 distinct protein products, of which 10 would be
predicted to contain the protease domain (Table S1). To inves-
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tigate precursor abundance, the presence of precursors during
viral replicationwas examined byWestern blotting (Fig. 3). The
identity of the observed precursors was assigned based on reac-
tivity with either NS6 or NS5 antisera, predicted molecular
weight, comparing migration on SDS-PAGE to a transfected
stable form of the individual precursor (Fig. S1), and previously
published observations (6). NS6- (Fig. 3A) and NS5-containing
precursors (Fig. 3B) were observed as early as 3–4 h post-infec-
tion, although the predominantNS6-containing precursor seen
throughout infection was in fact NS4–6. The majority of the
other predicted NS6-containing precursors could be identified
including full-length NS1/2–7 (Fig. 3, A and B).
Although the NS6–7 precursor was previously suggested to
be themajor formofNS6 contributing to norovirus polyprotein
cleavage based on increased activity in vitro compared with
mature NS6 (9), our data would indicate that it is produced at
relatively low levels. Mature, fully-processed NS6 appears to be
the major form of NS6 present over the course of infection.
Infectious virus production occurs from 5 h post-infection
onwards (Fig. 3C) at times when the mature form of NS6 and
the NS4–6 and NS4–7 precursors are the major forms of NS6
present at detectable levels.
To examine if the localization of NS6 was influenced by the
context of the precursors in which it is contained, we used crude
fractionation to separate cells into cytoplasmic and membrane-
associated fractions (Fig. 3D). The distribution of the soluble
cytoplasmic and membrane-associated protein marker pro-
teins glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and voltage-dependent anion channel (VDAC) confirmed suc-
cessful fractionation (27). TheMNVNS1/2, NS3, andNS4 pro-
Figure 1. Norovirus protease producedduring authentic viral replication inefficiently cleaves a cytoplasmic-localizedprotease substrate.A,genome
schematic of themurine norovirus genome highlighting themajor open reading frames and the components of the polyprotein. B, schematic of the CFP-YFP
FRET sensor highlighting the NS1/2-NS3 boundary cleavage site. C,Western blot analysis of HEK-293T cells co-transfected with the FRET sensor and eitherWT
or catalytically inactive protease (WT and H30A, respectively), or BV-2 cells electroporated with in vitro transcribed RNA encoding the FRET sensor and
subsequently infected atm.o.i. 10 TCID50/cell withMNV for 9 h. HighermolecularweightNS6 containing isoformsproducedduring viral infection are indicated
with asterisks. Note that the left- and right-hand regions of the NS6 Western blotting were imaged at different intensities to compensate for the lower NS6
signal intensity in infected cells. D, confocal microscopy of HeLa-CD300lf cells transfected with the FRET sensor and either co-transfected with an NS6
expression construct (NS6) and harvested at 18 h post-transfection, or infected with MNV (MNV) at a m.o.i. of 10 TCID50/cell at 6 h post-transfection, and
harvested at 12 h post-infection. The FRET sensor was visualized in the CFP and YFP channels, the protease with antisera against NS6, and nuclei stained with
DAPI. All experiments were repeated two times, with the exception of C,which was repeated three times. In each case one representative dataset is shown.
Regulation of norovirus protease activity during infection
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teins are known to be membrane associated (18, 21), and our
results confirmedNS3was restricted to themembrane fraction.
NS7 associates with the RC, but lacks a predicted transmem-
brane domain and could be found in both fractions. The distri-
bution of NS5-containing precursors was used as a surrogate
for NS6 due to the high degree of overlap with NS6-containing
precursors and the greater sensitivity of the antisera. High
molecular weight precursors containing NS1/2, NS3, or NS4
were absent from the soluble cytoplasmic fraction. In particu-
lar, the most abundant higher molecular weight precursor
(NS4–7) was exclusively isolated in the membrane fraction.
Proteins present in the soluble cytoplasmic fraction included
fully processed NS5, a protein that may represent NS4–5 or
NS5–6, and NS5–7. NS4–6 was present but less abundant in
the cytoplasmic than membrane fraction. Some15 kDa pro-
teins were identified in the membrane fraction that may repre-
sent modified forms of NS5, or breakdown products. Taken
together these data confirm that precursor forms of the noro-
virus replicase proteins impart distinct patterns of localization
on polyprotein constituents, which can differ from their fully
processed forms.
Precursor forms of the norovirus protease are proteolytically
active in a cell-free system but show variable activity in cells
As NS6-containing precursors showed variation in their
localization in infected cells, we hypothesized that this would
also result in variation in their ability to cleave substrates. To
test this hypothesis, active, stable forms of these precursors
were generated by alaninemutagenesis of the P1 residue (28) at
each cleavage site. Of the 21 polyprotein products that can be
generated by NS6-mediated polyprotein cleavage, 10 contain
NS6 (Fig. 4A). All protease-containing precursors could be
readily expressed in vitro and in transfected cells, although to
varying degrees (Fig. 4, B and C). Expression in both systems
yielded proteins of the expected molecular weights (Fig. 4A,
Table S1). We next examined the ability of each precursor to
cleave two different substrates; the ORF1-FRET-H30A sub-
strate, and PABP, a cellular protein involved in translation that
we previously identified as being cleaved by NS6 during noro-
virus infection (14).When unlabeled in vitro translated norovi-
rus protease-containing precursor proteins were incubated
with in vitro translated [35S]methionine-labeled PABP, cleav-
age products were observed (Fig. 4D). As expected, cleavage
products were not observed upon incubation of PABPwith cat-
alytically inactive protease (H30A). It is noteworthy that only a
fraction of the PABP produced in vitrowas cleaved, fitting with
our previous observations (14).When the same experimentwas
performed with [35S]methionine-labeled CFP/YFP FRET sen-
sor, all of the active precursors demonstrated proteolytic activ-
ity in vitro (Fig. S2).
Upon co-expression of the protease precursors and FLAG-
tagged PABP in cells, a C-terminal PABP cleavage product,
detected by virtue of the C-terminal FLAG tag, was only ob-
served when co-expressed with NS6, NS6–7, NS5–6, and
NS5–7(Fig. 4E). It is possible that lower expression levels of
some of the larger precursors may have contributed to the
observed lack of PABP cleavage. However, relative to the
NS6–7 precursor, NS5–7 andNS4–6were expressed to some-
what similar levels (76 and 49%, respectively) and yet NS4–6
showed10% PABP cleavage. These data strongly suggest that
the lack of PABP cleavage observed with these precursors
depends on the properties of the individual precursors, and not
expression levels.
The ability of the precursors to cleave a protease substrate
that was localized to the viral replication complex was exam-
ined by co-transfection of cells with plasmids expressing the
precursors and the ORF1-FRET-H30A FRET substrate (Fig.
Figure 2. Targeting protease substrates to the norovirus replication complex enhances cleavage by NS6. A, Western blotting of cells BSR-T7 cells
transfected with either proteolytically active (MNV-FLC) or inactive (MNV-H30A) full-length infectious MNV clone, or polyprotein fused to the FRET sensor
(ORF1-FRET-WT, ORF1-FRET-H30A). Samples were lysed at 18 h post-transfection. B, confocal microscopy of BSR-T7 cells fixed at 18 h post-transfection with
ORF1-FRET-WT or ORF1-FRET-H30A constructs. The FRET substrate was visualized in the CFP and YFP channels, and nuclei stained with DAPI. All experiments
were repeated two times, with one representative dataset shown.
Regulation of norovirus protease activity during infection
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4F). FRET substrate cleavage was observed in all cases except
when co-transfected with a catalytically inactive mature prote-
ase. In a limited number of cases, in addition to the fully cleaved
FRET substrate, additional larger CFP/YFP containing precur-
sors were observed with some protease-containing precursors
that were not detected following co-expressionwith themature
protease. Together these data highlight that the context in
which NS6 is expressed and the localization of any given sub-
strate, alters the relative efficiency of substrate cleavage.
NS6 precursor localization is determined by fusion of NS6with
membrane-bound polyprotein components and intra-
replication complex interactions
To examine how the context in which NS6 is expressed
affects its localizationwe examined the localization of each pre-
cursor inHeLa cells expressing theMNV receptor (CD300lf) by
confocal microscopy (Fig. 5). The mature fully processed form
of NS6 and the NS5–6 precursor showed predominantly cyto-
plasmic localization, with some nuclear localization. The local-
ization of the other precursors was more varied. NS6–7 also
showed some degree of nuclear localization but was largely
localized to the cytoplasm. NS5–7 was exclusively localized to
the cytoplasm but also formed some cytoplasmic puncta.
NS4–6 and NS4–7 showed reticular localization, reminiscent
of RC localization. A detailed analysis of the localization of
the longer precursors was confounded by the relatively poor
expression and toxicity of these precursors following trans-
fection, however, a limited number of cells could be visual-
ized by confocal microscopy (Fig. S3). The NS3-containing
precursors NS3–6 and NS3–7 localized to small, spherical
Figure 3. Accumulation of polyprotein precursors during MNV infection. BV-2 cells were infected at a m.o.i. of 10 TCID50/cell, and harvested at the
indicated times post-infection.Western blot analysiswith antisera against (A) NS6 or (B) NS5/VPg revealed the high levels of precursor proteins present at early
stages of infection. To ensure efficient transfer and resolution of the various precursors, samples were separated on both 7.5 (upper) and 17.5% (lower)
SDS-PAGE gels prior to transfer andWestern blotting. C, infectious virus produced across the time course was determined by TCID50 following freeze-thaw to
release intracellular virus. D, to investigate precursor localization, BV-2 cells were infected at m.o.i. 10 and harvested at 9 h post-infection where they were
subject to fractionation into soluble cytoplasmic, and cytoplasmic membrane-associated fractions. Lysates were blotted for viral and cellular markers as
indicated. All experiments with the exception of C were repeated two times, with one representative dataset shown. The virus titer experiments in C were
performed in triplicate and error bars represent standard deviation. Where unambiguous identification of the specific precursor was not possible due to
co-migration and antibody reactivity, both possible precursors are named and this is indicated with ‘*’.
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cytoplasmic membranous structures, whereas the NS1/2–6
and NS1/2–7 precursors were largely cytoplasmic, with
some cytoplasmic, possibly membrane-associated puncta,
observed on the case of NS1/2–6. In summary, we found that
the precursors containing NS4 and NS3 imparted membrane
localization on NS6, consistent with these proteins localiz-
ing to the viral RC. These data were also consistent with the
poor efficiency with which these precursors cleave PABP
(Fig. 4E).
Previous studies indicate that NS7 localizes almost exclu-
sively to the viral RC during infection, but when expressed
alone has amore diffuse localization (18, 26, 29). The lack of RC
localization observed for NS7-containing precursors suggested
that other factors present in infected cells might cause NS7 and
NS7-containing precursors to be relocalized to the RC. To test
this hypothesis we examined the impact of viral infection
on the localization of each NS6-containing precursor (Fig. 5).
Although the localization of mature NS6, NS4–6, and NS4–7
was not altered upon infection, the NS5–6, NS6–7, andNS5–7
precursors were redistributed to the viral RC. In the case of
NS5–6, whereas cytoplasmic and nuclear localization was still
visible, there was clear enrichment at the viral RC as evident by
colocalization with viral dsRNA. NS6–7 and NS5–7 showed a
more pronounced relocalization following infection, with
the vast majority of these precursors localized to the RC.
This suggests that whereas NS5–6, NS5–7, and NS6–7 all
possess the ability to cleave PABP when transfected into cells
(Fig. 4E), in the context of infection, the re-localization of
these proteins to the RC limits the contribution of these
precursors to PABP cleavage. These data suggest NS6 and to
a lesser extent NS5–6 is likely responsible for the majority of
PABP cleavage during infection.
Figure 4. Activity of NS6-containing stable precursors. FLAG-tagged forms of the various protease-containing precursors were generated bymutagenesis
of the P1 residue at each cleavage site to an alanine. A H30A mutation within the protease abolished proteolytic activity. A, a schematic illustrating the 10
possible NS6-containing precursors generated by NS6 cleavage of the polyprotein. Protease-containing precursors may all be observed following: B, in vitro
translation of the precursors incorporating [35S]Met labeling followed by phosphorimaging, or C, expression in BSR-T7 cells visualized by Western blotting.
Incubation of unlabeled in vitro translated precursors with [35S]methionine-labeled substrate demonstrates cleavage of the (D) cellular substrate PABP. E,
Westernblottingof BSR-T7 cells harvested at 18hpost-transfectionwith theprecursors and FLAG-PABP reveals only a subset of precursors cleave PABP in cells.
FLAG-tagged precursors are also visible on this image and are indicatedwith an asterisk (*). F,Western blotting of BSR-T7 cells co-expressingORF1-FRET-H30A
as substrate for trans-cleavage by co-expressed protease precursors shows cleavage of this substrate by all precursors at 18 h post-transfection. For E, the
amount of cleavage product relative to that observed with the NS6–7 precursor and F, loss of the full-length substrate relative to that observed H30Amutant
was determined by densitometry. The levels of cleavage are indicated below. 0–10% cleavage, 11–50% cleavage *, 51–90% cleavage **, 91–100%
cleavage ***. All experiments were repeated two times, with one representative dataset shown.
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Identification of protein–protein interactions between
norovirus proteins
The relocalization of NS7-containing precursors to the viral
RC upon infection highlighted the potential role of interactions
between viral components to tetherNS6-containing precursors
to the viral RC.We therefore examined the network of interac-
tions between norovirus replicase proteins to determine which
of thesemight impact on precursor localization. To this aimwe
used the LUMIER system (30, 31) to map all the interactions
between individualMNVproteins (Fig. 6 and Fig. S4). A similar
analysis was also performed for GI.1 and GII.4 human norovi-
rus (Figs. S5 and S6) to identify conserved intra-RC protein–
protein interactions. Strong self-association was observed with
NS1/2,NS4,NS7, and themajor andminor capsid proteinsVP1
and VP2. The N-terminal components of the polyprotein
NS1/2, NS3, and NS4 interacted with each other, all of which
have previously been shown to localize to cytoplasmic mem-
branes to initiate RC formation for the related feline calicivirus
(32). As expected, a robust interaction between the VP1 and
VP2 capsid proteins was seen along with VP1–NS7 and NS1/
2–NS7 interactions. These latter interactions fit with our pre-
vious observations of the impact of VP1 andNS1/2 on polymer-
ase function (33). A interaction was also observed betweenNS5
and NS7, in keeping with the role of NS5 in serving as a protein
primer for RNA synthesis. These data suggest that the redistri-
bution of the NS6-containing precursors NS5–6, NS6–7, and
NS5–7 to the viral RC is therefore the likely result of interac-
tions between NS1/2 and NS7, which in the case of NS5–6
could occur via the formation of a NS5–6NS7NS1/2 complex.
Fusion to N-terminal replication complex components permits
effective cleavage of fused substrates by the norovirus
protease in trans
To examine the minimum features required for the correct
localization of a substrate to the viral RC and its subsequent
cleavage, a range of truncation and deletion mutants in the
ORF1-FRET-H30A construct were generated (Fig. 7A). Active
RC localized viral proteasewas provided in trans by co-express-
ing the FRET substrates with a MNV full-length cDNA clone
with either aWT (MNV-FLC) or catalytically inactive protease
(MNV-H30A).
The N-terminal truncations all displayed some degree of
cleavage with the NS7-FRET substrate being cleaved the least
efficiently (Fig. 7B). Although the fusion of NS7 alone to a sub-
strate was sufficient to allow trans cleavage, C-terminal trunca-
tions demonstrated that NS7 was not essential as the NS1/2–6,
Figure 5. Confocal microscopy of protease precursors in mock or MNV-infected cells. HeLa-CD300lf cells were transfected with the various protease
precursor constructs and at 6 h post-transfection, mock- or infected with MNV at m.o.i. 10. The cells were fixed and processed for microscopy at 12 h
post-infection. Nuclei were visualized with DAPI, the precursors with anti-FLAG antisera, and infected cells with anti-dsRNA antisera. All experiments were
repeated two times, and 3 fields of view imaged for cells transfected with each protease precursor. One representative image for each condition is shown.
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NS1/2–5, andNS1/2–4 fusions were all cleaved efficiently (Fig.
7C). The NS1/2–3 and NS1/2 fusions showed progressively
poorer cleavage of the fused substrate.
Finally, the impact of internal deletions on FRET substrate
cleavage was examined (Fig. 7D). The NS4 mutant showed a
minordefect incleavage,whichmayhavebeendue to thechimeric
nature of theNS3/5-cleavage site generated by the deletion. Single
deletions of NS3, NS4, NS5, andNS6 all permitted efficient cleav-
age. From these data it is apparent that no single region of the
polyproteinwas essential for cleavage of a fused substrate, but that
several regions of the polyprotein (NS1/2–4 or NS7) appeared
sufficient. These regions matched those identified earlier as suffi-
cient for RC localization (Fig. 6), either directly, or through inter-
actions with other viral RC components.
Discussion
The generation of viral replicase components from a single
large polyprotein is a mechanism conserved in many ssRNA
viruses including noroviruses. The regulated production of
viral precursors, often with distinct functions, enables the
expansion of functional coding capacity without a concomitant
increase in viral genome size.
In the case of noroviruses, 21 possible precursors can be gen-
erated by NS6 cleavage of the polyprotein, 10 of which contain
the protease. In this study we confirm that all 10 of these pro-
tease-containing precursors represent active forms of the pro-
tease, although spatial sequestration of a number of these
precursor forms controls their substrate accessibility. Due to
similarity with other caliciviruses, where the protease and po-
lymerase (NS6–7) remain uncleaved, NS6–7 had previously
been suggested to represent the dominant form of NS6 proteo-
lytic activity (34). In support of this hypothesis, NS6–7 retains
both proteolytic and polymerase activity while fused (9, 10), can
more efficiently nucleotidylate NS5 than NS7 alone (35), and
NS6–7 has higher proteolytic activity than NS6 alone in vitro
(34). However, our data questions the extent to which this pre-
cursor may contribute to these activities as we identified the
NS4–6 precursor as the most abundant precursor form pro-
duced over the course of an infection.Wealso found thatNS6–7
doesnot localize directly to the viral RC, but instead requires other
viral factors such as NS1/2 for this localization. In addition, we
havepreviously shown that theNS6–7–cleavage site is efficiently
cleaved, consistent with the extremely low levels of NS6–7
observed throughout our time course experiments (7). Al-
though abundant, the diffuse localization of fully cleaved NS6
would result in lower concentrations of this form of the prote-
ase both within the replication complex and throughout the
Figure6.Componentsof thenorovirus replicationcomplexexhibithomo-andheteromeric interactions.HEK-293Tcells expressingproteinAandRenilla
luciferase fusions of the variousMNVproteinswere used for LUMIER analysis to identify protein–protein interactions. Thenumbers are robust Z-scores. Positive
protein–protein interactions are colored by the strength of interactionwithweak interactions showing in pale yellow, with the strongest interactions in purple.
Protein expression was confirmed by Western blotting (Fig. S4). LUMIER experiments were performed in quadruplicate.
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cytoplasm as a whole. This would prevent efficient cleavage by
NS6 until very late times post-infection. We would therefore
hypothesize that NS4–6 represents the form of the protease
responsible for the majority of trans polyprotein cleavage
observed during norovirus infection. The cytoplasmic localiza-
tion of mature NS6 could provide a mechanism of controlling
the levels of viral protein cleavage by expelling excess protease
from the RC, and thus avoiding runaway levels of proteolysis as
polyprotein abundance increases. In addition, this may allow
for the temporal regulation of the cleavage of certain cellular
substrates. It should, however, be noted that whereas this study
primarily focuses on trans-cleavage by the protease, cis-cleav-
agemost likely plays an important role in norovirus polyprotein
processing and will require further research.
In a recent study we identified PABP as a cellular substrate of
the norovirus protease (14). Cleavage of PABP at late times
post-infection partially accounted for inhibition of host trans-
lation and diminished production of innate immune regulatory
proteins duringMNV infection. Transfection of a noncleavable
form of PABP resulted in reduced MNV replication (14). The
mechanismbehind the temporal regulation of PABP cleavage is
unknown as mature protease is produced early in infection.
From the data presented here, the shorter, nonmembrane-as-
sociated forms ofNS6more effectively cleaved PABP. PABP is a
cytoplasmic protein much like the unfused FRET substrate.
Although the fully-cleaved NS6 is the most abundant form of
the protease formuch of infection, its diffuse localizationwould
be expected to result in lower concentrations of total protease
in the cytoplasm, compared with the replication complex that
would also possess the membrane-associated protease precur-
sors. This hypothesis is consistent with the strong replication
complex localization observed using anti-NS6 antisera in
MNV-infected cells. The concentration of NS6 activity within
the RC until late times post-infection may represent the means
by which PABP cleavage is temporally regulated, with PABP
cleavage only observed once cytoplasmic NS6 concentrations
have reached a threshold level.
A network of interactions between viral replication complex
proteins, their precursor forms, and a range of cellular proteins
is required to establish the formation of a functional viral RC
(36, 37). The interactions between the feline calicivirus repli-
case proteins have been previously investigated by our group
using the yeast two-hybrid system (38). In the current study we
extended this to include noroviruses, identifying a network of
Figure 7. Mutagenesis of polyprotein-FRET fusions reveals the importance of individual polyprotein components for replication complex targeting
and substrate cleavage. A, schematic illustrating the various N-, C-, and internal deletion mutants generated from ORF1-FRET-H30A. These mutants were
transfected into BSR-T7 cells to function as trans-cleavage substrates. WT or proteolytically inactive full-length clone (MNV-FLC, MNV-H30A) was provided in
trans to determine cleavage efficiency. Samples were harvested at 18 h post-transfection. N-terminal (B), C-terminal (C), and internal (D) deletions are shown.
Substrate cleavage was assessed using anti-GFP antisera. ORF1-FRET-WT was used as a positive control (). For clarity the position of either the full-length
(mock cells) or fully-processed cleavage product (MNV-infected cells) is highlighted with a red asterisk (*). The proportion of the full-length polyprotein-FRET
fusion showing cleavagewasdeterminedbydensitometry and calculated from the relative abundanceof the individual full-length FRET fusion in thepresence
of MNV-FLC compared with its MNV-H30A control. 0–10% cleavage  , 11–50% cleavage  *, 51–90% cleavage  **, 91–100% cleavage  ***. All
experiments were repeated two times, the second replicate is shown in Fig. S7.
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evolutionarily conserved interactions. Surprisingly, we observed
no direct interactions with the mature NS6 and any other viral
proteins. Further studies are required to determinewhether this is
due to confounding effects of the additional sequences added for
the LUMIER assay. However, NS6 has the potential to interact
withNS1/2,NS5, andVP1whenpart of theNS6–7precursor, and
NS4–6 precursors would also be expected to interact withNS1/2
and NS3 through interactions with the NS4 component of
the precursor. Several distinctions between norovirus protein–
protein interactions and the previous calicivirus protein interac-
tion study were observed. FCV p76 (equivalent to NS6–7) weakly
interactedwith theminor capsid protein (38), whereas no interac-
tions between VP2 and the nonstructural proteins were observed
for the noroviruses. For norovirusesNS1/2 appears to play the key
role in binding anumber of the nonstructural proteins together by
interacting withNS3, NS4, andNS7, with FCV p32 playing a sim-
ilar role (38). However, the self-interactions of NS3 and NS4
observed in the LUMIER data were not conserved in their FCV
p39 and P40 equivalents (38).
The alphaviruses represent the best-characterized example
of polyprotein cleavage driving the staging of events in the viral
life cycle throughout replication (13). Compared with norovi-
ruses, the alphaviruses have a simpler polyprotein with two
alternate forms P123 and P1234 produced by stop codon read-
through. The successive processing of this polyprotein at the
P34, P12, and P23 junctions, respectively, controls a shift in
viral transcription from negative to positive sense transcription
(13). Accumulation of the protease, and control of cis- and
trans-cleavage activity throughout infection drives these shifts
in precursor populations and thus yields a mechanism for tem-
poral regulation of viral replication.
Althoughour current understanding of the roles of norovirus
precursor proteins and polyprotein cleavage is less developed
than for the alphaviruses, the localization, interactions, and
cleavage patterns of the various protease precursors gives rise
to a basic mechanistic model for how polyprotein cleavage
could regulate some aspects of the norovirus life cycle. Follow-
ing release of the viral genome into the cytoplasm, pioneer
rounds of translation of the polyprotein from the incoming
genome occur. The synthesis of viral negative sense RNA is
thought to occur via a de novo initiation mechanism that is
enhanced by an interaction between the viral capsid protein
VP1 and the polymerase NS7 (39, 40). The production of viral
VPg-linked positive sense RNA can then occur. Analyses of
NS5/VPg-linked RNA produced in norovirus-infected cells
have to date only found fully processedNS5 linked to RNA (16).
However, experimentswith the distantly related picornaviruses
showed that in cases where the NS5–6 equivalent (3BC) cleav-
age site was mutated, viable virus was obtained and 3BC could
be identified bound to the RNA (42). This suggests that the
priming functions of NS5 may not require the fully processed
protein. However, our group and others have confirmed that
the fully processed NS5 is most efficient at binding to eukary-
otic initiation factor proteins and therefore translation of viral
proteins (16, 43). For example, Leen and colleagues (43) dem-
onstrated that disruption of NS5–6 cleavage abolished the
interaction ofNS5with the eIF4GHEATdomain. Regulation of
the levels of NS5-containing precursors may therefore provide
amechanismof temporal regulation of viral RNAsynthesis, due
to the progression in precursor abundance from dominant
NS4–6 andNS4–7 forms at early times, to later timeswhen the
fully cleaved and shorter precursors (NS4–5, NS5–6) are more
abundant. Negative sense RNA synthesis would be anticipated
to dominate until sufficient NS5 is present in a suitable (pre-
sumably shorter) precursor form to permit sense transcription.
In addition this temporal regulation of the NS5 precursor state
may also control levels of translation, although how distinct the
NS5-cleavage state requirements for efficient translation are
from those for positive sense RNA synthesis remains to be fully
elucidated.
In conclusion, our study identified a mechanism by which
noroviruses may regulate protease activity. This is achieved by
both the temporal control of precursor production and the
spatial regulation this imparts either directly or indirectly via
intra-RC protein–protein interactions with other viral repli-
case components. Membrane tethering keeps precursors asso-
ciated with the RC, serving to concentrate their activity and
ensure efficient cleavage of viral or RC-associated substrates. At
late times shorter forms of the protease lacking either a trans-
membrane fusion partner such as NS4, or the ability to interact
indirectly with the replication complex via NS7 dominate.
These forms are no longer sequestered at the RC and are capa-
ble of cleaving cytoplasmic substrates. This understanding of
which forms of the protease are most active throughout infec-
tion, and their regulationmay serve to guide future drug design
efforts against the protease and other RC components.
Experimental procedures
Cells and viruses
Murine BV-2 cells were used for infection experiments (25);
human HeLa cells expressing the murine norovirus receptor
(HeLa-CD300lf) and hamster BSR-T7 cells were used for trans-
fection and microscopy experiments. Experiments using fowl-
pox T7-mediated expression of the polyprotein, or polyprotein
fusions from theMNV reverse genetics systemwere performed
in BSR-T7 cells as described (44). LUMIER assays were per-
formed in unmodified HEK-293T cells.
All infections were performed with murine norovirus strain
CW1 (44). Preparation and titration of virus stocks by TCID50
was performed as described (45). All infections were performed
at high multiplicity of infection (m.o.i.: 10 TCID50/cell). Cells
were cultured in Dulbecco’s modified Eagle’s medium supple-
mented with penicillin/streptomycin, 10% serum, and were
maintained at 37 °C, 5% CO2.With the exception of BV-2 cells,
transfections were performed in antibiotic-free medium using
Lipofectamine 2000 (Life Technologies) as per the manufac-
turer’s recommendations. BV-2 cells were electroporated with
in vitro transcribed RNAs using the Neon electroporation sys-
tem (Life Technologies) as described previously (46).
Plasmids andmolecular cloning
The FRET plasmid usedwas essentially as described in Ref. 7.
To avoid difficulties in PCR amplification of the FRET sensor
(CFP-cleavable linker-YFP) due to high sequence identity be-
tween the CFP and YFP coding sequences, this was re-cloned
using a modified YFP nucleotide sequence while maintaining
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the original linker and protein sequences (sequence available
upon request). The generation of the FLAG-PABP plasmid has
been described previously (14).
N-terminally FLAG-tagged stable forms of all the potential
NS6 containing precursors were generated in pTriex1.1 (Nova-
gen) using pT7 MNV 3RZ (44) as a template. In each precur-
sor, all the known cleavage sites had their P1 residuemutated to
alanine to inhibit cleavage. Cloning was accomplished by Gib-
son assembly into the NcoI and XhoI restriction sites of
pTriex1.1.
The pT7MNV 3RZ plasmid used has been described previ-
ously (44), and represents a full-length clone of theMNVCW1
strain (DQ285629), and is referred to as MNV-FLC. The pro-
teolytically inactive form of this plasmid was generated by
alaninemutagenesis ofHis-30within theNS6 sequence (MNV-
H30A). The full-length FRET fusion plasmid (ORF1-FRET-
WT) and inactive mutant (ORF1-FRET-H30A) were derived
from pT7 MNV 3RZ and had the subgenomic region deleted
and the FRET sensor fused to NS7 in place of the NS7 stop
codon. A poly(A) tail was included between the stop codon of
the FRET sensor and the HDV ribozyme. This permitted
expression of this protein by transfection of the plasmid into
BSR-T7 cells infectedwith fowlpox-T7, or by electroporation of
in vitro transcribed RNA into BV-2 cells.
The various deletion constructs based on ORF1-FRET-
H30A were generated by a Gibson assembly approach. N-ter-
minal deletions all incorporated the methionine from NS1/2.
C-terminal deletions fused the FRET sensor to the C-terminal
most protein, which had its C-terminal P1 residue directly join-
ing the FRET sensor mutated to alanine to prevent off-target
cleavage between the C-terminal protein and CFP. For internal
deletions, the sequence deleted extended from the P1 of the
N-terminal cleavage site to the P1 of the C-terminal cleavage
site of the protein of interest resulting in the production of a
chimeric cleavage site. For example, in the NS3 deletion
mutant, the cleavage site between NS1/2 and NS4 consists of
the P side residues of the NS1/2-NS3 cleavage site and the P
side residues of the NS3–NS4 cleavage site.
All MNV and genogroup I and II HuNoV genes encoding
individual proteinswere cloned fromMNV-1 (strainCW1) and
Norwalk (GI.1) into the Gateway pDONR207 entry plasmid,
andMD145 (GII.4) strains into theGatewaypDONR221 entry
plasmid. N-terminal Renilla reniformis luciferase (RL) and Sac-
charomyces aureusproteinA (PA) fusion protein plasmidswere
generated in pcDNA3-RL-GW and pTrex-Dest30-PA expres-
sion vectors, respectively, using the Gateway Clonase II
enzyme recombination system (Invitrogen). The negative con-
trol plasmid consisted of a double protein A fusion protein
(PA–PA). Validation of LUMIER assays was performed using
positive control plasmids consisting of RL–c-Jun and PA–c-
Fos fusion proteins.
Antibodies
Recombinant NS6 from GI.1, GII.4, and MNV was prepared
in Escherichia coli as described previously (47), combined, and
used as antigen for preparation of rabbit polyclonal antisera.
The resulting sera was affinity purified againstMNVNS6. NS3,
NS5 (VPg), andNS7 antibodieswere prepared in our laboratory
previously, and anti-NS5 was affinity purified against Cherry-
tagged MNV NS5. Antisera to GAPDH (Ambion), VDAC
(Abcam), PABP (Cell Signaling), green fluorescent protein
(Abcam) were purchased from the indicated vendors.
Western blotting
Cells were lysed in RIPA buffer (50 mM Tris, pH 8, 150 mM
NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS) and protein
concentrations were determined by BCA assay (Pierce). Sam-
ples were then mixed with SDS sample loading buffer. We and
others5 have observed that heating samples containing NS6, or
someof the otherNS6-containing precursors can cause these to
precipitate in the sample buffer. As such, blotting was per-
formed by mixing the sample with SDS sample loading buffer
and then immediately loading the sample onto the gel without
heating. Samples were supplemented with RNase mixture, and
the use of lower sample concentrations (3–5 g/well) also
helped prevent smearing. Sampleswere run on SDS-PAGEgels,
transferred to nitrocellulose membranes, blocked, and probed
by standard protocols. Detection was accomplished using IR-
dye 680- or 800-conjugated secondary antibodies followed by
imaging on a Li-Cor Odyssey imager.
Relative quantification of protease cleavage activity by
densitometry
Due to the impact that the high degree of variation in protein
size has on the relative transfer efficiency of substrate and prod-
uct to the membrane used forWestern blotting, along with the
variation in the expression levels and stability of both protease
and substrate, quantification of cleavage efficiency was per-
formed using a relative scale to allow comparison within any
given experiment. Comparison of cleavage levels between the
various FRET-containing precursors was achieved by densi-
tometry ofWestern blotting images obtained on aLi-CorOdys-
sey imager using the Image Studio Lite software (Li-Cor). As
the precursors yielded a range of different cleavage intermedi-
ates, cleavage was assessed by comparing the relative abun-
dance of the full-length uncleaved substrate between lanes ex-
pressing the substrate of interest alongside active or inactive
protease, or where using MNV infection, by comparing in-
fected or mock-infected cells expressing the substrate. To nor-
malize for background, the intensity of the same molecular
weight region of amock-transfected control lane was used. The
relative level of cleavage was therefore determined as: % cleav-
age  100  ((substrate plus active protease/substrate plus
inactive protease) 	 100). As cleavage of PABP by NS6 alone
results in cleavage at a single site, quantification of PABP cleav-
age (Fig. 4E) was performed using the relative amount of the
cleavage product. The level of PABP cleavage was deter-
mined relative to that observed in cells expressing the
NS6–7 precursor as: % cleavage  ((PABP plus protease/
PABP plus NS6–7) 	 100). In all cases, the relative cleavage
efficiencies have been expressed as four classes: 0–10%
cleavage  , 11–50% cleavage  *, 51–90% cleavage  **,
and 91–100% cleavage  ***.
5 E. Leen, personal communication.
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Confocal microscopy
Cells were grown on glass coverslips, transfected, and
infected as indicated above. At the relevant time point, the cov-
erslips were washed with cold PBS, fixed in 4% paraformalde-
hyde in PBS for 10 min on ice, and permeabilized with PBS
containing 0.2% Triton X-100 and 4% paraformaldehyde for an
additional 10 min at room temperature. Aldehyde groups were
quenched with 0.2 M glycine in PBS. Subsequent antibody incu-
bations and washing steps followed standard protocols and
have been described previously (48). Alexa Fluor fluorescent
secondary antibodies were obtained from Molecular Probes
and used at the manufacturer’s recommended dilution. Cover-
slips weremounted on glass slides usingMowiol supplemented
with DAPI. Imaging was performed on a Leica Sp5 confocal
microscope using a 	63 oil objective. Image analysis was per-
formed in the Leica Lite software (Leica Microsystems).
In vitro translation reactions
In vitro translation assays were performed with 1 g of tem-
plate plasmid and the T7 coupled in vitro transcription-trans-
lation kit (Promega). Reactions were either performed with
[35S]methionine labeling, or unlabeled as indicated in the text.
Half-size reactions (25 l) were incubated at 30 °C for 1 h and
30 min. At the end of the incubation the reactions were mixed
with an equal volume of Trans-stop buffer (10 mM EDTA, 100
ng/ml of RNase A) and incubated at room temperature for 30
min.
For experiments assessing cleavage of [35S]methionine-la-
beled substrate by unlabeled protease/precursors, after addi-
tion of trans-stop, 5l of labeled substratewasmixedwith 15l
of unlabeled protease. This was then mixed with 4 volumes (80
l) of protease assay buffer (10 mM HEPES, pH 7.6, 0.1%
CHAPS, 10 mM DTT, and 30% glycerol (47)) and incubated at
37 °C for 48 h. All samples were then combined with reducing
SDS-PAGE loading buffer, resolved on a denaturing 17.5%
SDS-PAGE gel, dried, and imaged using a Typhoon FLA 7000
phosphorimager.
LUMIER assay
All assays were performed in quadruplicate. 96-Well plates
containing 5 	 104 HEK-293T cells per well in 100 l of Dul-
becco’s modified Eagle’s medium supplemented with 15% fetal
bovine serumwere seeded 12 h prior transfection. Co-transfec-
tions were performed with 60 ng of combined bait and prey
plasmidswith 0.3l of Lipofectamine 2000 (Invitrogen) in 30l
of Opti-MEM I (Gibco) per well. After 24 h incubation, cells
were lysed for 10min at 4 °Cwith shaking using 30l of ice-cold
LUMIER lysis buffer (PBS, pH 7.4 (Mg/Ca free), 1% Triton
X-100, 0.1% BSA, 1 mM DTT) with 1% Halt EDTA-free Prote-
ase/Phosphatase Inhibitor Mixture (Pierce) and benzonase
nuclease (Novagen). Each supernatant was transferred in a
96-well V-bottomplate, and then centrifuged at 2000	 g for 15
min at 4 °C. 20 l of each supernatant was retained and trans-
ferred to a new white flat bottom plate.
Dynabeads M280 sheep anti-rabbit IgG-coated magnetic
beads (Invitrogen) were washed 3 times with the LUMIER
washing buffer (PBS, pH 7.4 (Mg/Ca free), 0.1% BSA, 1 mM
DTT, 1 mM ATP) then coupled overnight at 4 °C with a poly-
clonal anti-protein A rabbit antibody (Sigma). The beads were
washed 4 times with LUMIER washing buffer. 2 l of beads in
30 l of LUMIER washing buffer was added to each well con-
taining the lysate supernatants.
After 90 min of incubation on a shaker at 4 °C, 60 l of
LUMIER washing buffer was added to each plate and mixed.
After transferring 10 l of supernatant per well to new 96-well
white plates to measure unbound activity, immunoprecipita-
tion plateswerewashed six timeswith LUMIERwashing buffer.
Renilla luciferase activity was measured in both immunopre-
cipitation and unbound plates on a GloMax luminometer (Pro-
mega). Data were normalized to background ratios and Robust
Z-score (RZ) calculated (49).
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Figure S1. Confirmation of precursor identity in MNV-infected cell lysates. Lysates from 
BV-2 cells mock- or infected with MNV at MOI 10 and harvested at 9h post-infection, were 
compared to HEK-293T cell lysates mock- or transfected with plasmids expressing stable 
forms of the various precursors. Precursors were visualized by anti-NS6 and anti-NS5 
antisera to assess co-migration. Note that the addition of a FLAG-tag on the precursors adds 
at additional 1.14kDa which results in some discrepancy in the migration of the smaller 
precursors. All experiments were repeated two times. 
 
  

Figure S2. Cleavage of the FRET sensor by norovirus protease precursors in vitro. 
Incubation of unlabeled in vitro translated norovirus protease precursors with 35S Methionine-
labeled in vitro translated substrate demonstrates cleavage of the FRET sensor. All 
experiments were repeated two times. 
  

Figure S3. Confocal microscopy of N-terminal norovirus protease precursors. HeLa-
CD300lf cells were transfected with plasmids expressing NS3-6, NS3-7, NS1/2-6 and NS1/2-
7. At 18h post-transfection the cells were harvested and precursors visualized by anti-NS6 
staining. Nuclei were visualized with DAPI. All experiments were repeated  two times, and 3 
fields of view imaged for each protease precursor. One representative image for each 
condition is shown. 
 
  

Figure S4. Western blotting of MNV LUMIER assay reagents confirms expression.  Western 
blotting of lysates prepared from HEK-293T cells transfected with A) Renilla-luciferase or B) 
Protein-A fusions of the various MNV proteins confirms their expression and migration at the 
expected size.  Samples were harvested at 24h post-transfection. Lumier experiments were 
performed in quadruplicate. 
 
  

Figure S5. LUMIER assay reveals GI.1 replication complex interactions are conserved 
between GI.1 and MNV. A) HEK-293T cells expressing Protein-A and Renilla luciferase 
fusions of the various GI.1 human norovirus proteins were used for LUMIER analysis to 
identify protein:protein interactions. The numbers are robust z-scores. Positive protein:protein 
interactions are coloured by the strength of interaction with weak interactions showing in pale 
yellow, with the strongest interactions in purple. Western blotting of lysates prepared from 
HEK-293T cells transfected with B) Renilla-luciferase or C) Protein-A fusions of the various 
GI.1 norovirus proteins confirms their expression and migration at the expected size. Samples 
were harvested at 24h post-transfection. Lumier experiments were performed in 
quadruplicate. 
 
  

Figure S6. LUMIER assay reveals GII.4 replication complex interactions are conserved 
between GII.4 and MNV. A) HEK-293T cells expressing Protein-A and Renilla luciferase 
fusions of the various GII.4 human norovirus proteins were used for LUMIER analysis to 
identify protein:protein interactions. The numbers are robust z-scores. Positive protein:protein 
interactions are coloured by the strength of interaction with weak interactions showing in pale 
yellow, with the strongest interactions in purple. Western blotting of lysates prepared from 
HEK-293T cells transfected with B) Renilla-luciferase or C) Protein-A fusions of the various 
GII.4 norovirus proteins confirms their expression and migration at the expected size. 
Samples were harvested at 24h post-transfection. Lumier experiments were performed in 
quadruplicate. 
 
  

Figure S7. Replicate data relating to Figure 7. Polyprotein-FRET fusions mutants were 
transfected into BSR-T7 cells to function as trans-cleavage substrates. WT or proteolytically-
inactive full length clone (MNV-FLC, MNV-H30A) was provided in trans to determine 
cleavage efficiency. Samples were harvested at 18h post-transfection. A) N-terminal, B) C-
terminal and C) Internal deletions are shown. Substrate cleavage was assessed using anti-GFP 
antisera. ORF1-FRET-WT was used as a positive control (+). For clarity the position of either 
the full length (Mock cells) or fully-processed cleavage product (MNV infected cells) is 
highlighted with a red asterisk (*).  
  

Table S1. Predicted molecular weights of norovirus proteins and precursor forms. The first 
tab lists all the potential norovirus proteins and precursors that can be derived from the 
polyprotein. The second and third tabs list all the NS5- or NS6-containing precursors ranked 
by molecular weight from largest to smallest. Predicted molecular weight was calculated 
using the ExPASy server ProtParam tool. 
 
